Alpha 1-antitrypsin deficiency-related alleles Z and S and the risk of Wegener's granulomatosis

Arthritis Care and Research

Volumn 62, Issue 12, 2010, Pages 3760-3767

  Mahr, Alfred D ^a   Edberg, Jeffrey C ^b   Stone, John H ^c   Hoffman, Gary S ^d   St clair, E William ^e   Specks, Ulrich ^f   Dellaripa, Paul F ^g   Seo, Philip ^h   Spiera, Robert F ⁱ   Rouhani, Farshid N ^j   Brantly, Mark L ^j   Merkel, Peter A ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f MAYO CLINIC   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

^h JOHNS HOPKINS UNIVERSITY   (United States)

ⁱ HOSPITAL FOR SPECIAL SURGERY   (United States)

^j UNIVERSITY OF FLORIDA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; MYELOBLASTIN; MYELOPEROXIDASE; SERPINA1 PROTEIN, HUMAN;

ADULT; ALLELE; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CAUCASIAN; CHURG STRAUSS SYNDROME; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC POLYANGIITIS; WEGENER GRANULOMATOSIS; AGED; CASE CONTROL STUDY; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; RISK FACTOR; CODOMINANCE; COHORT ANALYSIS; DISEASE PREDISPOSITION; PRIORITY JOURNAL; S ALLELE; STATISTICAL ANALYSIS; Z ALLELE;

ADULT; AGED; ALLELES; ALPHA 1-ANTITRYPSIN; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; WEGENER GRANULOMATOSIS;

EID: 78650065423     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.27742     Document Type: Article

References (26)

1. Bosch X, Guilabert A, Font J,. Antineutrophil cytoplasmic antibodies. Lancet 2006; 368: 404-18.
2. Mahr AD, Neogi T, Merkel PA,. Epidemiology of Wegener's granulomatosis: lessons from descriptive studies and analyses of genetic and environmental risk determinants. Clin Exp Rheumatol 2006; 24: S82-91.
3. Esnault VL, Testa A, Audrain M, Roge C, Hamidou M, Barrier JH, et al. Alpha 1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis. Kidney Int 1993; 43: 1329-32.
4. Elzouki AN, Segelmark M, Wieslander J, Eriksson S,. Strong link between the α1-antitrypsin PiZ allele and Wegener's granulomatosis. J Intern Med 1994; 236: 543-8.
5. Lhotta K, Vogel W, Meisl T, Buxbaum M, Neyer U, Sandholzer C, et al. Alpha 1-antitrypsin phenotypes in patients with anti-neutrophil cytoplasmic antibody-positive vasculitis. Clin Sci (Lond) 1994; 87: 693-5.
6. Savige JA, Chang L, Cook L, Burdon J, Daskalakis M, Doery J,. Alpha 1-antitrypsin deficiency and anti-proteinase 3 antibodies in anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis. Clin Exp Immunol 1995; 100: 194-7.
7. Baslund B, Szpirt W, Eriksson S, Elzouki AN, Wiik A, Wieslander J, et al. Complexes between proteinase 3, α1-antitrypsin and proteinase 3 anti-neutrophil cytoplasm autoantibodies: a comparison between α1-antitrypsin PiZ allele carriers and non-carriers with Wegener's granulomatosis. Eur J Clin Invest 1996; 26: 786-92.
8. Griffith ME, Lovegrove JU, Gaskin G, Whitehouse DB, Pusey CD,. C-antineutrophil cytoplasmic antibody positivity in vasculitis patients is associated with the Z allele of alpha-1-antitrypsin, and P-antineutrophil cytoplasmic antibody positivity with the S allele. Nephrol Dial Transplant 1996; 11: 438-43.
9. Callea F, Gregorini G, Sinico A, Gonzales G, Bossolasco M, Salvidio G, et al. Alpha 1-Antitrypsin (AAT) deficiency and ANCA-positive systemic vasculitis: genetic and clinical implications. Eur J Clin Invest 1997; 27: 696-702.
10. Esnault VL, Audrain MA, Sesboue R,. Alpha-1-antitrypsin phenotyping in ANCA-associated diseases: one of several arguments for protease/antiprotease imbalance in systemic vasculitis. Exp Clin Immunogenet 1997; 14: 206-13.
11. Borgmann S, Endisch G, Urban S, Sitter T, Fricke H,. A linkage disequilibrium between genes at the serine protease inhibitor gene cluster on chromosome 14q32.1 is associated with Wegener's granulomatosis. Clin Immunol 2001; 98: 244-8.
12. Kleinbaum DG, Kupper LL, Morgenstern H,. Epidemiologic research: principles and quantitative methods. New York: John Wiley & Sons; 1982.
13. WGET Research Group. Design of the Wegener's Granulomatosis Etanercept Trial (WGET). Control Clin Trials 2002; 23: 450-68.
14. De Serres FJ, Blanco I, Fernandez-Bustillo E,. Genetic epidemiology of α-1 antitrypsin deficiency in North America and Australia/New Zealand: Australia, Canada, New Zealand and the United States of America. Clin Genet 2003; 64: 382-97.
15. Bartels CL, Marchetti AL, Edward Highsmith W, Tsongalis GJ,. Real time PCR detection of the PI*Z and PI*S mutations associated with alpha-1 antitrypsin deficiency. Am J Transl Res 2009; 1: 406-11.
16. Stern C,. The Hardy-Weinberg law. Science 1943; 97: 137-8.
17. Akaike H,. A new look at the statistical model identification. IEEE Trans Automat Contr 1974; 19: 716-23.
18. Stone JH, Hoffman GS, Merkel PA, Min YI, Uhlfelder ML, Hellmann DB, et al, for the International Network for the Study of the Systemic Vasculitides (INSSYS). A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. Arthritis Rheum 2001; 44: 912-20.
19. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency [published erratum appears in Am J Respir Crit Care Med 2004;169:656]. Am J Respir Crit Care Med 2003; 168: 818-900.
20. Stoller JK, Aboussouan LS,. Alpha1-antitrypsin deficiency. Lancet 2005; 365: 2225-36.
21. Segelmark M, Elzouki AN, Wieslander J, Eriksson S,. The PiZ gene of α1-antitrypsin as a determinant of outcome in PR3-ANCA-positive vasculitis. Kidney Int 1995; 48: 844-50.
22. Campbell H, Rudan I,. Interpretation of genetic association studies in complex disease. Pharmacogenomics J 2002; 2: 349-60.
23. Audrain MA, Sesboue R, Baranger TA, Elliott J, Testa A, Martin JP, et al. Analysis of anti-neutrophil cytoplasmic antibodies (ANCA): frequency and specificity in a sample of 191 homozygous (PiZZ) α1-antitrypsin-deficient subjects. Nephrol Dial Transplant 2001; 16: 39-44.
24. Ioannidis JP,. Genetic associations: false or true? Trends Mol Med 2003; 9: 135-8.
25. Price AL, Butler J, Patterson N, Capelli C, Pascali VL, Scarnicci F, et al. Discerning the ancestry of European Americans in genetic association studies. PLoS Genet 2008; 4: e236.
26. Luisetti M, Seersholm N,. Alpha1-antitrypsin deficiency. 1: epidemiology of α1-antitrypsin deficiency. Thorax 2004; 59: 164-9.